Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ductal, Breast × Alpelisib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 22 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Lymphangioma 2 Hyperglycemia 2 Hereditary Sensory and Autonomic Neuropathies 2 Endometrial Neoplasms 2 Vascular Malformations 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases, Vascular 1 Hormone Receptor Positive Breast Carcinoma 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 HER2-positive Metastatic Breast Cancer 1 Genetic Diseases, Inborn 1 Fallopian Tube Neoplasms 1 Arteriovenous Malformations 1 Advanced HER2+Breast Cancer 1 Advanced Breast Cancer 1

Interventions

Radiotherapy 2 talimogene laherparepvec 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiation 1 Paclitaxel 1 Mastectomy, Segmental 1 Mastectomy 1 Mass Spectrometry 1 Immunohistochemistry 1 Gene Expression Profiling 1 Fulvestrant 1 Fluorescent Antibody Technique 1 Counseling 1 Chromatography, Liquid 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡